✦ LIBER ✦

A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma

✍ Scribed by Andrew H. Ko, Hagop Youssoufian, Jayne Gurtler, Karel Dicke, Omar Kayaleh, Heinz-Josef Lenz, Mark Keaton, Terry Katz, Shaila Ballal, Eric K. Rowinsky

Book ID: 113064540
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 177 KB
Volume: 30
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-011-9691-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab plus gemcitabine and oxalipl

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial

✍ David Fogelman; Mehrdad Jafari; Gauri R. Varadhachary; Henry Xiong; Susie Bulloc 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB

A Randomized Phase II Study of Paclitaxe

A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer

✍ Adam Brufsky; Karen Hoelzer; Thaddeus Beck; Robert Whorf; Mark Keaton; Padma Nad 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 441 KB

First-line therapy with gemcitabine and

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

✍ Djelila Allouache; Sulochana R Gawande; Michele Tubiana-Hulin; Nicole Tubiana-Ma 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 275 KB

A phase II study of weekly irinotecan as

A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer

✍ Hideki Ueno; Takuji Okusaka; Akihiro Funakoshi; Hiroshi Ishii; Kenji Yamao; Osam 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 328 KB

Final results of a phase II study ofnab-

Final results of a phase II study ofnab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

✍ Christopher Lobo; Gilberto Lopes; Odalys Baez; Aurelio Castrellon; Annapoorna Fe 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 268 KB

Phase II Study of Gemcitabine and Bevaci

Phase II Study of Gemcitabine and Bevacizumab As First-Line Treatment in Taxane-Pretreated, HER2-Negative, Locally Recurrent or Metastatic Breast Cancer

✍ Rachel Borson; Graydon Harker; James Reeves; Thaddeus Beck; Steven Hager; Willia 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 387 KB